1/1

FIEO Registered Export Ready

PanWell-DSR

Name: PanWell-DSR
Brand: panwell-dsr
SKU: 8591174
Availability: InStoreOnly

Sold by mediwell pharmaceuticals · Service Provider , Manufacturer, Brand Owner, Distributor, Exporter, Wholesaler · Mumbai, Maharashtra, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Available in bottles or blister strips as per customer requirement

Shelf life / longevity

As per product specification

HSN Code

30049099

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for mediwell pharmaceuticals.

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Mumbai Dispatch on request FIEO member

mediwell pharmaceuticals

Service Provider , Manufacturer, Brand Owner, Distributor, Exporter, Wholesaler · Mumbai, Maharashtra, India

Registered address: Mumbai Suburban, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

2025

Employees

–

GST

27BNOPA9689R2ZO

IEC code

BNOPA9689R

Export markets

Global markets

GlobalLinker Member Since

Nov 2025

Turnover

On request

Incorporation Type

On request

Certifications & Awards

GST IEC FORM 20 B FORM 20 D FORM 21 B

Product details

What are the specifications of this product?

Overview

PanWell-DSR is a high-performance, dual-action gastrointestinal medication designed for the effective management of acid-peptic disorders. By combining a potent Proton Pump Inhibitor (PPI) with a reliable prokinetic agent, PanWell-DSR offers comprehensive relief from acidity, heartburn, and associated nausea.Therapeutic CompositionPantoprazole Sodium IP: 40 mg (As gastro-resistant pellets)Domperidone IP: 30 mg (As prolonged release Pellets)Uses:Gastroesophageal Reflux Disease (GERD): Rapid relief from acid reflux and heartburn.Peptic & Duodenal Ulcers: Promotes mucosal healing by maintaining optimal gastric pHDyspepsia: Reduces bloating and fullness through improved gastric motility.NSAID-Induced Gastritis: Protects the stomach lining for patients on long-term pain medication

Product Description

PanWell-DSR is a premium combination therapy formulated to address the global rise in acid-peptic disorders. It integrates a Proton Pump Inhibitor (PPI) with a Prokinetic agent in a specialized Multi-Particulate Delivery System (MPDS) to ensure 24-hour symptom control with a single daily dose.

PanWell-DSR utilizes a Pellet-in-Capsule system designed for maximum bioavailability:
Pantoprazole (40mg) Enteric-Coated Pellets: Engineered to bypass the acidic environment of the stomach and release only in the alkaline environment of the small intestine.
Domperidone (30mg) Sustained-Release Pellets: Formulated for a controlled, prolonged release over 24 hours. This eliminates the "rollercoaster effect" of immediate-release medications, providing steady anti-emetic and prokinetic action to prevent reflux.

Main Therapeutic Uses of PanWell-DSR

Management of GERD (Gastroesophageal Reflux Disease)
Treatment of Erosive Esophagitis
Healing of Peptic and Duodenal Ulcers
Reduction of Bloating and Flatulence
Control of Nausea and Vomiting
Relief from Functional Dyspepsia

Description provided by mediwell pharmaceuticals.

Specifications

Pantoprazole Sodium IP	40 mg per capsule (gastro-resistant pellets)
Domperidone IP	30 mg per capsule (prolonged-release pellets)
Dosage Form	Pellet-in-Capsule
Delivery System	Multi-Particulate Delivery System (MPDS)
Indications	GERD, erosive esophagitis, peptic and duodenal ulcers, NSAID-induced gastritis, dyspepsia
Release Mechanism	Enteric coating for Pantoprazole; Sustained release for Domperidone
Recommended Dosage	Once daily oral administration
Shelf Life	As per packaging (typically 24 months)
Packaging	Available in bottles or blister strips as per customer requirement
Storage Conditions	Store in a cool, dry place away from direct sunlight

Use cases

Category	Pharmaceuticals > Gastrointestinal Medications > Acid Peptic Disorder Treatments
Primary application	Wholesale, distribution, and international sourcing
Brand	panwell-dsr
Product type	Product

Logistics & handling

Lead time	On request
Packaging	Available in bottles or blister strips as per customer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing PanWell-DSR. Answers compiled from verified sellers' commercial terms and platform data.

Q: How does the Multi-Particulate Delivery System (MPDS) enhance PanWell-DSR's efficacy?

A: The MPDS pellet-in-capsule technology allows Pantoprazole pellets to resist stomach acid and release only in the small intestine, improving absorption, while Domperidone pellets provide sustained release to maintain steady prokinetic activity over 24 hours. This ensures continuous symptom relief and better therapeutic outcomes.

Q: What advantages does PanWell-DSR offer over single-agent therapies for acid-peptic conditions?

A: PanWell-DSR combines a Proton Pump Inhibitor and a Prokinetic agent, offering dual action that not only reduces gastric acid secretion but also improves gastric motility. This comprehensive approach addresses both acidity and delayed gastric emptying, providing faster and more effective relief than single-agent treatments.

Q: Is PanWell-DSR suitable for patients on long-term NSAID therapy?

A: Yes, PanWell-DSR is indicated for NSAID-induced gastritis as it protects the gastric mucosa by reducing acid secretion and promoting healing, thereby minimizing gastrointestinal side effects common in patients on prolonged NSAID use.

Q: What is the recommended dosage and administration for PanWell-DSR?

A: PanWell-DSR is designed for once-daily oral administration, providing 24-hour symptom control through its sustained-release formulation, enhancing patient compliance.

Q: Can PanWell-DSR be used to treat functional dyspepsia symptoms?

A: Yes, PanWell-DSR improves gastric motility and reduces bloating and fullness, making it effective for managing symptoms of functional dyspepsia in addition to acid suppression.

Question not answered? Ask sellers directly — typical response within 4 hours.